https://www.yiliao.com/index.php?action=history&feed=atom&title=Bcl-xL
Bcl-xL - 版本历史
2026-04-21T08:42:57Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=Bcl-xL&diff=316018&oldid=prev
2026年1月28日 (三) 10:31 77921020
2026-01-28T10:31:39Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2026年1月28日 (三) 10:31的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l27" >第27行：</td>
<td colspan="2" class="diff-lineno">第27行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">编码基因</th></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">编码基因</th></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[BCL2L1]] (20q11.21)</td></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[BCL2L1]] (20q11.21)</td></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> </tr></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> <tr></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> <th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">氨基酸数</th></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> <td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;"><strong>233 aa</strong> (Isoform 1)</td></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td></tr>
</table>
77921020
https://www.yiliao.com/index.php?title=Bcl-xL&diff=316017&oldid=prev
77921020：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-28T10:26:44Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>Bcl-xL</strong>（B-cell lymphoma-extra large），由基因 <strong>[[BCL2L1]]</strong> 编码，是 Bcl-2 家族中功能最强大的<strong>抗凋亡蛋白</strong>之一。它主要定位于线粒体外膜，通过异源二聚化结合促凋亡蛋白（如 [[Bax]]、[[Bak]]）来维持线粒体完整性，防止细胞色素 c 释放。与 Bcl-2 不同，Bcl-xL 是<strong>[[血小板]]</strong>和<strong>成熟神经元</strong>存活的必需因子。在临床上，Bcl-xL 的过度表达与多种实体瘤（如肝癌、结直肠癌）的化疗耐药密切相关。针对 Bcl-xL 的药物开发曾因严重的剂量限制性毒性（血小板减少症）而受阻，目前通过 <strong>[[PROTAC]]</strong> 技术实现“血小板豁免”是该领域的最新突破。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">Bcl-xL</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">BCL2L1 / Anti-apoptotic Protein (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
[Image:Bcl-xL_structure_hydrophobic_groove]<br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">结构：BH1-4 结构域形成的疏水槽</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">基础生物学参数</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">编码基因</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[BCL2L1]] (20q11.21)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">分子量</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">~26 kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">亚细胞定位</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">线粒体外膜 (MOM)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">主要异构体</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">Bcl-xL (长型, 抗凋亡)<br>Bcl-xS (短型, 促凋亡)</td><br />
</tr><br />
<br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">功能网络</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">结合对象</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">[[Bax]], [[Bak]], [[Bad]] (最强结合)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">生理功能</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;"><strong>血小板寿命维持</strong>, 神经保护</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">上游调控</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[STAT3]], [[NF-κB]]</td><br />
</tr><br />
<br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">临床转化</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">高表达癌种</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;">肝细胞癌 (HCC), 结直肠癌</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">抑制剂毒性</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;"><strong>血小板减少症</strong> (Dose-limiting)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">靶向药物</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;">[[Navitoclax]] (ABT-263)<br>DT2216 (PROTAC)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569;">非敏药物</th><br />
<td style="padding: 6px 12px; color: #64748b;">[[Venetoclax]] (不结合Bcl-xL)</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：MOMP 的守门人</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
Bcl-xL 的功能依赖于其结构中的疏水凹槽，通过“隔离”策略来阻止凋亡：<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>隔离效应子 (Sequestering Effectors)：</strong> <br />
<br>Bcl-xL 结合并隔离已经激活的膜结合型 <strong>[[Bax]]</strong> 或 <strong>[[Bak]]</strong>，阻止它们寡聚化形成线粒体膜孔。这种结合非常紧密，使得细胞即使在有压力的情况下也能维持线粒体完整。</li><br />
<li style="margin-bottom: 12px;"><strong>对 Bad 的偏好：</strong> <br />
<br>Bcl-xL 对 BH3-only 蛋白 <strong>[[Bad]]</strong> 的亲和力显著高于 Bcl-2。这在神经元和血小板中尤为重要，因为这些细胞主要依赖 Bcl-xL 来中和 Bad 的促凋亡活性。</li><br />
<li style="margin-bottom: 12px;"><strong>逆向转运 (Retrotranslocation)：</strong> <br />
<br>研究表明，Bcl-xL 还能主动将 Bax 从线粒体膜“拉回”细胞质中（Retrotranslocation），从而降低线粒体上的 Bax 浓度，动态防止 MOMP 发生。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">临床挑战：血小板的阿喀琉斯之踵</h2><br />
<br />
<div style="background-color: #f0f9ff; border-left: 5px solid #1e40af; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #1e40af; font-size: 1.1em;">为什么 Navitoclax 会失败？</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
血小板不表达 Bcl-2，其存活<strong>完全依赖</strong> Bcl-xL 来维持 Bak 的抑制状态。第一代 BH3 模拟物 <strong>[[Navitoclax]] (ABT-263)</strong> 同时抑制 Bcl-2 和 Bcl-xL。患者服用后，血小板中的 Bcl-xL 被抑制，释放的 Bak 迅速导致线粒体穿孔，引发急性的、剂量限制性的<strong>血小板减少症</strong>。这也促成了特异性 Bcl-2 抑制剂（Venetoclax）的诞生。<br />
</p><br />
</div><br />
<br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">药物策略</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">机制原理</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">优缺点</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">Pan-Bcl抑制 (Navitoclax)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">同时阻断 Bcl-2/Bcl-xL/Bcl-w。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; color: #b91c1c;">疗效广谱，但毒性太大（杀血小板）。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">Bcl-2 特异性 (Venetoclax)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">仅阻断 Bcl-2，不碰 Bcl-xL。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; color: #16a34a;">血小板安全，但对 Bcl-xL 依赖的实体瘤无效。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600; background-color: #dcfce7;">PROTAC (DT2216)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7;">利用 E3 连接酶 (VHL) 降解 Bcl-xL。<strong>血小板缺乏 VHL 活性</strong>，因此不受影响。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #dcfce7; color: #16a34a; font-weight: bold;">完美解决毒性问题，是目前的研发热点。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献 [Academic Review]</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Boise LH, et al. (1993).</strong> <em>bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.</em> <strong>[[Cell]]</strong>. <br><br />
<span style="color: #475569;">[点评]：历史性文献，首次克隆了 Bcl-xL 基因，并描述了其长（L）短（S）两种剪接变体相反的生物学功能。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Mason KD, et al. (2007).</strong> <em>Programmed cell death of the cell of origin: the platelet.</em> <strong>[[Cell]]</strong>. <br><br />
<span style="color: #475569;">[点评]：确立了 Bcl-xL 作为血小板存活决定因子的地位，解释了 ABT-737/263 导致血小板减少症的分子机制。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[3] <strong>Khan S, et al. (2019).</strong> <em>A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity.</em> <strong>[[Nature Medicine]]</strong>. <br><br />
<span style="color: #475569;">[点评]：开发了 DT2216，巧妙利用血小板中 E3 连接酶表达谱的差异，实现了在杀伤肿瘤的同时保护血小板。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
Bcl-xL · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">上游调控</td><br />
<td style="padding: 10px 15px; color: #334155;">[[STAT3]] (转录激活) • [[NF-κB]] • [[Epo]] (促红素)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">家族成员</td><br />
<td style="padding: 10px 15px; color: #334155;">[[Bcl-2]] • [[Mcl-1]] • [[Bax]] • [[Bak]] • [[Bad]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">临床应用</td><br />
<td style="padding: 10px 15px; color: #334155;">[[抗衰老]] (Senolytics) • [[PROTAC]] • [[化疗增敏]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">副作用</td><br />
<td style="padding: 10px 15px; color: #334155;">[[血小板减少症]] (Thrombocytopenia)</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
77921020